Fosun integrates medical device business with U.S.-China mutual benefit joint venture company
Source: Internet
Author: User
KeywordsMedical devices Fosun USA
Fosun Medicine accounted for 51% of the shares, the U.S. and China mutual benefit accounted for 49% in several increase in U.S.-China mutual Benefit (CHDX.NASDAQ), Fosun Medicine (600196.SH) will be the cooperation between the two sides. 28th, Fosun and the U.S.-China mutual benefit signed a contract in Shanghai, announced that the two sides will jointly set up a new joint venture in Hong Kong, the U.S.-China Mutual Benefit Medical Co., Ltd. (hereinafter referred to as "U.S.-China mutual Benefit Medical care"), for the integration of the medical device business. Among them, Fosun Medicine injected into its existing medical device business (in addition to medical diagnostics), accounting for 51% of the joint venture company, the United States and China to inject all the medical equipment business, the joint venture company 49% Equity. Yesterday, Fosun Medical said that the future U.S.-China mutual benefit medical care will become Fosun medical equipment business integration platform. This is one of a series of initiatives for Fosun to establish various business development platforms. June 14 this year, Fosun Pharmaceutical and the wholly-owned subsidiary Fosun Industrial and the U.S.-China mutual benefit sign Agreement, the U.S.-China mutual benefit will be conditionally divided two times at 15 U.S. dollars per share price, to Fosun industry-oriented distribution of a total of 1.99 million common shares, Fosun industrial purchase of the common shares of the total price of about 29.86 million U.S. dollars. In accordance with the above agreement, the United States and China on August 27 to the Fosun issued 930,000 shares of a common stock, the remaining 1.06 million shares of a common stock issued by the company and the United States and China to complete the joint venture, the two sides of the medical device business integration can be carried out. After the completion of the additional, Fosun Medicine can hold the U.S.-China mutually beneficial 25% equity. After the completion of the joint venture can meet the U.S.-China mutual benefit of the second issue of the conditions, so that Fosun medicine to the United States and China's mutually beneficial shareholding ratio reached 25%, so as to successfully complete the entire U.S.-China mutually beneficial projects of all transactions to achieve strategic alliance cooperation between the two sides. Fosun Pharmaceutical Chairman Chen Qiyu said that the combination of Fosun Medicine and the U.S.-China mutual benefit brand is another milestone in the international Development strategy of Fosun Medicine, and it is also an important symbol of Fosun medicine to strengthen enterprise "endogenous integration and development". The new joint venture company in the future will be on both sides of the medical Device business optimization integration, so that Fosun medical equipment business scale up to a new level, perfect Fosun medical equipment plate from research and development, manufacturing to domestic and foreign marketing industry chain system. The US-China mutual benefit is an American health-care company that is targeting the Chinese market, providing health care and supplying large medical equipment. As an upgraded version of the U.S.-China mutual Benefit Medical Device business unit, the JV will continue to sell products from major multinational companies, including Siemens imaging equipment. At the same time, as the successor of Fosun Medical equipment business (in addition to clinical diagnostic products), the joint venture company will have dental products and supplies, medical suture products, medical polymer supplies manufacturing entities. "We have explored a number of strategic options for the medical devices business and have a greater potential for developing joint ventures with Fosun," said Robertalipson, president and chief executive officer of the US-China mutual benefit company, which can achieve advantages and mutual Roberta Ripson through business integration.Complement, produces the synergy the scale effect, thus achieves the two sides to operate alone cannot achieve the effect. ”
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.